Dissemination of the Metallo- -Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia
- 1 December 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (11), 1549-1556
- https://doi.org/10.1086/497831
Abstract
Background. The clinical utility of carbapenems is under threat because of the emergence of acquired metallo-β-lactamase (MBL) genes. We describe the first outbreak in Australia of infection and/or colonization with gram-negative pathogens carrying the MBL gene blaIMP-4.Keywords
This publication has 28 references indexed in Scilit:
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance ProgrammeJournal of Antimicrobial Chemotherapy, 2005
- Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from AustraliaJournal of Antimicrobial Chemotherapy, 2004
- Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilliDiagnostic Microbiology and Infectious Disease, 2004
- Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001)Journal of Antimicrobial Chemotherapy, 2004
- Epidemiology of Rifampin ADP-Ribosyltransferase ( arr-2 ) and Metallo-β-Lactamase ( bla IMP-4 ) Gene Cassettes in Class 1 Integrons in Acinetobacter Strains Isolated from Blood Cultures in 1997 to 2000Antimicrobial Agents and Chemotherapy, 2003
- Efficacy of β-Lactams for Treating Experimentally Induced Pneumonia Due to a Carbapenem-Hydrolyzing Metallo-β-Lactamase-Producing Strain of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2002
- Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New bla IMP Allele, bla IMP-7Antimicrobial Agents and Chemotherapy, 2002
- Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 EnzymeAntimicrobial Agents and Chemotherapy, 2001
- Hospital Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-1, a Novel Transferable Metallo- -LactamaseClinical Infectious Diseases, 2000